Mecit Kaplan
9PUBLICATIONS
105CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jun 26, 2025
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial.Yago Nieto, Pinaki Banerjee, Indreshpal Kaur
|Apr 04, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial.Yago Nieto, Pinaki Banerjee, Indreshpal Kaur
|Sep 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.Bijender Kumar, Anand Singh, Rafet Basar
|Jun 20, 2024
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.Sunil Acharya, Rafet Basar, May Daher
|Jan 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trial.David Marin, Ye Li, Rafet Basar
|Jul 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.Li Li, Vakul Mohanty, Jinzhuang Dou
Pageof 2
Frequent Collaborators
6 joint publications
Ye Li
6 joint publications
Hind Rafei
6 joint publications
Katayoun Rezvani
6 joint publications
Ken Chen
6 joint publications
May Daher
5 joint publications
Rafet Basar
4 joint publications
Natalie W Fowlkes
4 joint publications
Paul Lin
4 joint publications
Mayra Shanley
4 joint publications
Vakul Mohanty
